Children's Infectious Diseases Clinical Research Unit, Cape Town Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2011
NCT01479972
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Children's Infectious Diseases Clinical Research Unit (KID-CRU) | Children's Infectious Diseases Clinical Research Unit (KID-CRU), South Africa | Children's Infectious Diseases Clinical Research Unit (KID-CRU), Tygerberg, South Africa

Active Ingredients

Drugs in Phase 2 Trials (1)

bacille calmette-guerin (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tuberculosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1